{"schema_version":"secwatch.filing_event.v1","accession":"0001520138-24-000017","form_type":"8-K","ticker":"AXIL","cik":"0001718500","company_name":"Axil Brands, Inc.","filed_at":"2024-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.235137+00:00","generated_at":"2026-06-06T23:19:21.602813+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Reviv3 Procare effects 1-for-20 reverse stock split to meet NYSE American listing requirements","bullets":["Filed Certificate of Amendment on Jan 12, 2024; reverse split effective Jan 16, 2024 at 12:01 a.m. ET.","1-for-20 reverse stock split reduces outstanding shares from ~117M to ~5.85M, fractional shares rounded up.","Action intended to meet NYSE American initial listing requirement of $3.00 minimum bid price.","Common stock trades under RVIV; CUSIP post-split is 76151R206.","CEO states split supports anticipated exchange listing and corporate rebranding to AXIL Brands."],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-24-000017","json":"https://secwatch.observer/filing/0001520138-24-000017.json","markdown":"https://secwatch.observer/filing/0001520138-24-000017.md","text":"https://secwatch.observer/filing/0001520138-24-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1718500/000152013824000017/0001520138-24-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1718500/000152013824000017/rviv-20240116_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:19:21.602813+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2e249d87c64a82c6cafba77eb57eede35c529bc7","claim":"Axil Brands, Inc.: Filed a Certificate of Amendment to effect a 1-for-20 reverse stock split of common stock (effective 2024-01-16).","evidence_excerpt":"On January 12, 2024, Reviv3 Procare Company (the “Company”) filed a Certificate of Amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, with the Delaware Secretary of State to implement a reverse stock split of the Company’s issued shares of common stock, par value $0.0001 per share at a ratio of one (1) for twenty (20) approved by the Company’s Board of Directors, effective at 12:01 a.m. Eastern Time on January 16, 2024 (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1718500/000152013824000017/0001520138-24-000017-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}